NovaRomentin vs Derthona FbC Prediction

STIMS TERMINAL HAS ANALYSED THE RECENT TRAJECTORY FOR NOVAROMENTIN, IDENTIFYING A L-L-L-L-L SEQUENCE. CONTRASTING THIS, DERTHONA FBC EXHIBITS A D-D-L-W-L GRADIENT. CROSS-REFERENCING ARCHIVES IN DETECTS 1 H2H VICTORIES. BOTH SQUADS ARE OPERATING WITH VOLATILE TRANSITION DEFENCE COEFFICIENTS WITHIN THE SERIE D FRAMEWORK, SKEWING THE AGGREGATE MOMENTUM TOWARD THE SIDE CAPABLE OF MAINTAINING MIDFIELD ATTRITION TO SECURE POSSESSION.